• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Novartis` Remibrutinib First to Meet Phase III Endpoint in CIndU

    GLOBENEWSWIRE

    Novartis` Skin Disease Drug Gets Us Approval

    REUTERS

    Novartis Remibrutinib Data Confirm Efficacy And Safety In Urticaria

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.